VetMedUni biopharmaceutical spinout Marinomed Biotech has secured a $3.4m payment from a strategic tie-up with Link Health Pharma, after pausing its IPO process in November 2018.
Marinomed Biotech, an Austria-based biopharmaceutical spinout of University of Veterinary Medicine Vienna (VetMedUni), will receive €3m ($3.4m) in upfront payment through a strategic partnership with drug producer Link Health, ThePharmaLetter reported on Monday. The spinout will also receive milestone payments in the low eight-digit dollar range for each product developed under the strategic partnership. Founded…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
